KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) Return on Invested Capital (2021 - 2023)

Cardlytics (CDLX) has disclosed Return on Invested Capital for 3 consecutive years, with 2.16% as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Return on Invested Capital fell 209.0% year-over-year to 2.16%, compared with a TTM value of 2.16% through Mar 2023, down 209.0%, and an annual FY2022 reading of 0.84%, down 65.0% over the prior year.
  • Return on Invested Capital was 2.16% for Q1 2023 at Cardlytics, down from 1.15% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.07% in Q1 2022 and bottomed at 2.16% in Q1 2023.
  • Average Return on Invested Capital over 3 years is 0.65%, with a median of 0.18% recorded in 2022.
  • The sharpest move saw Return on Invested Capital crashed -100bps in 2022, then tumbled -209bps in 2023.
  • Year by year, Return on Invested Capital stood at 0.15% in 2021, then tumbled by -680bps to 1.15% in 2022, then tumbled by -88bps to 2.16% in 2023.
  • Business Quant data shows Return on Invested Capital for CDLX at 2.16% in Q1 2023, 1.15% in Q4 2022, and 0.15% in Q3 2022.